Gemcitabine-induced hemolytic uremic syndrome: a case report

被引：35

作者：

Brodowicz, T

Breiteneder, S

Wiltschke, C

Zielinski, CC

机构：

[1] Univ Hosp Vienna, Dept Med 1, Div Clin Oncol, A-1090 Vienna, Austria

[2] Univ Hosp Vienna, Dept Med 1, Chair Expt Med Oncol, A-1090 Vienna, Austria

[3] Univ Hosp Vienna, Dept Clin Pathol, A-1090 Vienna, Austria

[4] Ludwig Boltzmann Inst Clin Expt Oncol, Vienna, Austria

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1997年 / 89卷 / 24期

关键词：

D O I：

10.1093/jnci/89.24.1895

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1895 / 1896

页数：2

共 6 条

[1] PHASE-II TRIAL OF GEMCITABINE (2,2'-DIFLUORODEOXYCYTIDINE) IN PATIENTS WITH ADENOCARCINOMA OF THE PANCREAS [J].

CASPER, ES ;

GREEN, MR ;

KELSEN, DP ;

HEELAN, RT ;

BROWN, TD ;

FLOMBAUM, CD ;

TROCHANOWSKI, B ;

TARASSOFF, PG .

INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) :29-34

[2]

Fisher DC, 1996, BONE MARROW TRANSPL, V18, P193

[3]

FOSELLA FV, 1993, P AN M AM SOC CLIN, V12, P326

[4] HEMOLYTIC UREMIC SYNDROME FOLLOWING CISPLATIN, BLEOMYCIN, AND VINCRISTINE CHEMOTHERAPY - A REPORT OF A CASE AND A REVIEW OF THE LITERATURE [J].

GARDNER, G ;

MESLER, D ;

GITELMAN, HJ .

RENAL FAILURE, 1989, 11 (2-3) :133-137

[5] Safety profile of gemcitabine [J].

Tonato, M ;

Mosconi, AM ;

Martin, C .

ANTI-CANCER DRUGS, 1995, 6 :27-32

[6] Mitomycin-C induced hemolytic uremic syndrome: A case report and literature review [J].

Wu, DC ;

Liu, JM ;

Chen, YM ;

Yang, SL ;

Liu, SM ;

Chen, LT ;

WhangPeng, J .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (02) :115-118

← 1 →